Korean J Pancreas Biliary Tract.  2024 Jan;29(1):9-19. 10.15279/kpba.2024.29.1.9.

Ursodeoxycholic Acid Suppresses Epithelial-Mesenchymal Transition via Inhibition of Reactive Oxygen Species in Bile Duct Cancer Cells

Affiliations
  • 1Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea
  • 2Division of Gastroenterology, Hallym University Dongtan Sacred Heart Hospital, Hwasung, Korea

Abstract

Background
/Aim: Reactive oxygen species (ROS) are associated with the growth and invasion of malignant tumors. Ursodeoxycholic acid (UDCA) was proven to block the EGFR-MAPK signaling pathway and epithelial-mesenchymal transition (EMT) in bile duct cancer (BDC) cells. This study was performed to determine the effect of UDCA on ROS activity in BDC cells.
Methods
Human extrahepatic BDC cells were cultured. MTT assays evaluated cell viability, and ROS assay kit measured ROS. The western blot assays measured the expression levels of various target proteins. SiRNA was used for silencing of specific genes, and shRNA was used for over-expression of specific genes.
Results
UDCA suppressed DCA-induced production of peroxide and ROS, inhibited expression of PRX2, phosphorylated STAT3 and SOD2, and decreased expression of NOX2 and NOX4 in BDC cells. PRX2 and STAT3 were involved in inhibiting EMT by UDCA. UDCA restored the expression of catalase inhibited by DCA in BDC cells. Furthermore, overexpression of NOX4 using shRNA offset the antineoplastic effect of UDCA in BDC cells.
Conclusions
UDCA suppresses the production of ROS and enhances the elimination of ROS, inhibiting STAT3 and PRX2 associated with EMT in BDC cells. Accordingly, UDCA contributes to inhibiting the growth and invasiveness of BDC cells via suppression of ROS activity and EMT.

Keyword

Bile duct cancer; Reactive oxygen species; Epithelial-mesenchymal transition; STAT3 transcription factor; NADPH oxidase 2; 담도암; 활성산소; 상피-중간엽전환; STAT3 transcription factor; NADPH oxidase 2
Full Text Links
  • KJPBT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr